India received help from 52 countries during second wave of COVID-19, says Centre

New Delhi: International community came forward with offers of solidarity and assistance for specific medicines and equipment that were not immediately available in the country during the second wave of COVID-19 and material from 52 countries have been received till date, the government told the Rajya Sabha on Thursday.

Minister of State for External Affairs V Muraleedharan said in a written reply that India has imported 31.5 lakh units of Sputnik Component 1 and 4.5 lakh units of Sputnik Component 2 vaccine till date.

“During the unprecedented crisis of the second wave of COVID pandemic, the International community came forward with offers of solidarity and assistance for specific medicines and equipment that weren’t immediately available in country till such time our own domestic production improved,” he said.

“Foreign materials from 52 countries have been received till date including from government to government, private to government, private to private, Indian community associations and companies,” he added.

The minister said that donations were cleared through the Inter-Ministerial Committee that includes representatives of the Ministry of Health, Ministry of External Affairs (MEA), Niti Aayog, Department for Promotion of Industry and Internal Trade (DPIIT), Ministry of Home Affairs (MHA), Ministry of Health and Family Welfare (MoHFW).

  • Related Posts

    WHO launches new primary health care course to strengthen health systems globally

    Health is a human right – yet not everyone can access the health services they need, when and where they need them, without financial hardship. Primary health care (PHC) provides…

    Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

    Bengaluru: The Central Council for Research in Ayurvedic Sciences (CCRAS) has called for stronger scientific evidence, safety monitoring and translation of research into market-ready technologies to improve the credibility and…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    WHO launches new primary health care course to strengthen health systems globally

    WHO launches new primary health care course to strengthen health systems globally

    Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

    Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert